Infectious Diseases 1501 - Infectious Disease Alert - Jan 01, 2011

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Associate Editors
Hal B. Jenson, MD, FAAP
Professor of Pediatrics
Tufts University School of Medicine
Chief Academic Officer
Baystate Medical Center
Springfield, MA

Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine

Subjects:

  • Oral Rehydration Therapy Shows Effectiveness in Controlling Cholera in Haiti
  • Detecting Human Metapneumovirus in Young Children
  • Endotipsitis — Difficult to Diagnose, Difficult to Treat
  • Cranberry Juice Prophylaxis for UTIs: A Reason for Skepticism?
  • Should We Adopt a Pre-exposure Prophylaxis Approach for HIV Prevention?
  • Revised Guidelines for Perinatal Group B Streptococcal Disease
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, does research for the National Institute of Health (NIH), and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Peer Reviewer Timothy Jenkins, MD, and Associate Editor Hal B. Jenson, MD, FAAP, report no financial relationship relavent to this field of study. Associate Editor Dean L. Winslow, MD, FACP, FIDSA, is a speaker for Cubist Pharmaceuticals, and GSK, and is a consultant for Siemens Diagnostics.

Copyright 2011 AHC Media. All rights reserved.